Supportive care for patients with early breast cancer.
Breast cancer treatment currently requires the joint efforts of a multidisciplinary team to effectively combine chemotherapy, hormone therapy, biological agents, surgery and radiation therapy when needed. To develop such a treatment plan, it is important to know the benefits as well as the potential toxic effects of each therapy. Thus, many patients with early breast cancer complain of collateral adverse events such as fatigue, nausea, vomiting, loss of libido, hot flashes, night sweats or neuropathy due to the complex therapies they are receiving. To date, the treatment of such symptoms is an important issue that greatly affects the quality of life of these patients. In this review, we report the content of a multi-expert meeting where the incidence of and medical approach to some of the most common adverse events encountered during the treatment of patients with early breast cancer were analysed.
García-Estévez
Laura
L
Servicio de Oncología Médica, Centro Integral Oncológico Clara Campal, Madrid, Spain. lauraestevez@hospitaldemadrid.com
Tusquets
Ignasi
I
Alvarez
Isabel
I
Rodríguez
César
C
Fernández
Yolanda
Y
Seguí
Miguel Angel
MA
García-Mata
Jesús
J
Lluch
Ana
A
D001943:Breast Neoplasms / Q000175:diagnosis / Q000628:therapy*; D003131:Combined Modality Therapy; D018450:Disease Progression; D055088:Early Detection of Cancer; D005260:Female; D006801:Humans; D033183:Interdisciplinary Communication; D010166:Palliative Care / Q000379:methods; D010348:Patient Care Team